Introduction
Depression is a common mental disorder that is characterized by loss of interest or pleasure, feelings of guilt or low self-worth, disturbed sleep or appetite, low energy, and poor concentration. 1 Depression often occurs as a result of adverse life events, such as the loss of a significant person-object relationship or loss of health. However, it can also occur due to no apparent cause. These problems can become chronic or recurrent 
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Tilahune et al and lead to substantial impairment in an individual's ability to take care of their everyday responsibility. 2 Depression is associated with a combination of genetic, psychological, environmental, and biological factors. 3 The risk factors associated with depression include stress, impulsive behavior, alcohol or substance abuse, and family history of depression or suicide. Other factors such as poverty, severe or chronic medical conditions, insomnia, female sex, intimate partner violence, sexual abuse, and tobacco use are also associated with depression. 4 The review of research evidence available indicates that the primary health-care clinician's ability to detect depressive disorders is important to prevent suicide and reduce health-care cost because patients with depression visit health facilities frequently. 5 However, the clinician's ability to detect depression is sometimes affected by the presence of comorbidities. Literature has indicated that comorbidity between physical illness and depression often complicates the recognition, treatment, and prognosis of depression. 6 More than 150 million people suffer from depression at any point of time in the world. 7 Also, the World Health Organization (WHO) estimated that depression is the fourth most important contributor to the global burden of disease and comprised 4.4% of the total disability-adjusted life years in the year 2004. 8 The WHO estimated that nearly 15% of the global population on average suffered from depression at least once in their lives. Also, the WHO estimated that neuropsychiatric disorders account for a total of 28% of the global burden of disease, of which more than one-third are accounted for by depression. 8 In North America, the probability of having a major depression episode within a 1-year period of time is 3%-5% for males and 8%-10% for females. 9 Depression was the leading cause of disability as measured by years lived with disability and the fourth leading contributor to the global burden of disease in 2000. 9 By the year 2020, depression is projected to reach second place in the ranking of the major causes of disability-adjusted life years calculated for all ages and both sexes. 10 Depression accounts for 5% of the total burden of diseases from all causes.
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Mental disorders are more common in clinical than in community setting as evidenced by the study conducted in Kenya (n=2,770) among inpatient and outpatient clients. This study showed that 42% of the subjects had symptoms of mild and severe depression. Only 114 (4.1%) of subjects had a file or working diagnosis of a psychiatric condition. 12 Literature from high-income countries suggest that almost 20% of adults will have a mood disorder requiring treatment during their lifetime and that about 8% of adults will have a major depressive disorder during their lives. 13 In Ethiopia, depression contributes to about 6.5% of the burden of diseases. 14 The prevalence of depression in Ethiopia was reported to be 5%. 15 The World Health Organization report on mental health suggests that undiagnosed depression places a significant socioeconomic burden on individuals, families and community in terms of increased service needs, lost employment, reduced productivity, poor parental care with the risk of transgenerational effect, and an increased burden on caregivers. 16 The average annual health cost for depressed patients, including medical, pharmaceutical, and disabling costs, was 4.2 times higher than that of the general population. 17 Studies carried out so far in different countries of the world 5, [18] [19] [20] [21] [22] [23] [24] [25] [26] have shown that symptoms of depression among medical patients were common and were associated with various factors. However, little is known about the prevalence of depression among medical patients. Therefore, this study was performed to determine the prevalence of depression and factors associated with it among patients attending the medical outpatient department (OPD).
Materials and methods
An institution-based cross-sectional study design was conducted from March 1 to March 30, 2016 All patients who attended adult medical OPD at Adare Hospital were the source population, and those who were attending adult medical OPD at Adare Hospital during the study period and who fulfilled inclusion criteria were considered as study population. Clients who were already diagnosed with mental illness and unable to communicate during the interview as a result of critical illness were excluded from this study.
The sample size was determined using a single population proportion formula considering the following assumptions: standard normal distribution with confidence interval (CI) of 95% (Z=1.96), absolute precision or tolerable margin of error (d=0.05), and anticipated proportion of patients who experience depression =30.3% (P) taken from the study conducted in Malawi. 27 Since the source population was ,10,000, we used a correction formula and added 10% nonresponse rate; so, the final sample size was 326. 
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Unrecognized depression among OPD patients in ethiopia A systematic random sampling technique was used to select the respondents for interview. A total of 43,200 and 3,600 clients attend the medical OPD annually and monthly, respectively. The sampling fraction (K) was obtained by dividing monthly average number of patients attending outpatient department for the sample size, 3,600/326 which is 11. The first individual was selected using a lottery method, and the rest were selected at a regular interval using systematic random sampling method.
The Patient Health Questionnaire 9 (PHQ-9) was used to assess whether the respondents had experienced symptoms associated with depression within 2 weeks before the interview. The PHQ-9 has demonstrated acceptable reliability and validity. Sensitivity and specificity of PHQ-9 score was 88% for major depression. The PHQ-9 was translated and validated for use in Ethiopia. Depression was measured using PHQ-9 with a 3-point severity scale over the last 2 weeks. Based on the instrument standard, a PHQ-9 score $5 was considered as significant for meeting the symptoms of depression. The PHQ-9 incorporates the Diagnostic and Statistical Manual for Mental Disorder Version IV depression criteria along with other leading depression symptoms into a brief self-report tool. 28 The Amharic version of "PHQ-9" for screening of depression was utilized. Semistructured questionnaires were used to collect sociodemographic, substance use, and clinical factors. Current use of a substance was defined as substance use in the last 3 months.
Two nurses with diplomas who received a 2-day intensive training on data collection techniques were involved in data collection. The pretest was done at Melkaoda Hospital on 5% of sample, and Cronbach's α was used to check the reliability of the tool. The value of Cronbach's α was .0.71 for the entire tool. Data collection was supervised, and each questionnaire was checked for completeness by the supervisor on a daily basis.
Collected data were entered and analyzed using SPSS version 20 (IBM Corporation, Armonk, NY, USA). Descriptive statistics was used to identify the distribution of sociodemographic characteristics of the study participants. The prevalence estimates of depression were calculated. The distribution of PHQ-9 scores among men and women as well as the prevalence of each specific symptom was also estimated. Both bivariate and multivariate logistic regression analyses with 95% CI were used to see the association between each independent variables and depression. Finally, those variables that showed statistical significance at P,0.05 and 95% CI in the final model were reported as being independently associated with depression.
Ethical clearance was obtained from the ethical review board of Hawassa University, College of Medicine and Health Science. Ethical issues of the participants were addressed throughout the study. All participants of the study were provided with an informed consent form, clearly stating the objectives of the study and their right to refuse; the form also stated that if they did not want to answer any question, they had the right to do so. All participants were randomly selected without any discrimination on any ground. Filled out questionnaires were carefully handled, and all access to results was kept strictly within the members of the group.
Results
Three hundred and twenty-six clients were contacted, and 326 respondents gave a complete response with a response rate of 100%. The mean age of the clients was 34±13.1 years. The majority of participants were men (57.1%), married (53.1%), Protestant (50.9%), employed (34.9%), and Sidama by ethnicity (58.9%), and 8.9% of the respondents had no formal education. About 13.2% of clients were reported to have a family history of mental illness (Table 1) .
substance use status of study participants About 32.1% of respondents were current substance users, and of this, current users of khat, alcohol, and tobacco were 16.3%, 26.1%, and 8.6%, respectively.
current chronic medical illness of study participants
Of all respondents, 158 (48.1%) had chronic medical illness (Figure 1 ).
The prevalence of depression
According to PHQ-9, 80 (24.5%) of study subjects were identified as having a depressive episode in the 2 weeks preceding the survey, while detection rate of depression by the clinician was 0%. Women had higher prevalence (26.4%) of all depression symptoms compared with men (23.1%). From the total of nine items, loss of interest (56.4%) and feelings of tiredness (61.4%) were the most common symptoms reported among women, whereas restlessness was more common symptoms experienced by men (Table 2) .
Factors associated with depression
Determinants that had significant associations on bivariate analysis at P-value ,0.2 were then entered for multivariate analysis. The following variables were associated (P,0.05) with increased odds of depressive symptoms: depressive (Table 3) .
Discussion
The overall prevalence of depression among patients attending Adare Hospital was 24.5%. This finding is similar to the results of studies carried out in India (23.8%), 18 Malawi (30.3%), 27 France (25%), and the USA (19.2%), 29 but demonstrates a higher prevalence than that reported in South Korea primary care setting (14.1%). 19 The higher prevalence in the current study might reflect the particular psychosocial stresses experienced by this group of patients.
Women were 1.6 times more likely to experience depression compared with men. This finding is consistent with reports from Pakistan, 30 Nigeria, 31 and India. 18 It has been shown that mental health problems, particularly depression, affect women to a greater extent than men, and this finding is consistent across diverse societies and social contexts. 32 Proportionally, symptoms of depression were more common in women compared with men across all age groups. The reason might be the pressure created by their multiple roles and responsibilities, sex discrimination, and associated factors such as sex-based violence that contribute to women's poor mental health. 33 Depression was significantly associated with age. Study subjects aged .60 years were 4.1 times more likely to develop depression as compared with those aged 18-30 years. The finding in this study was consistent with the study conducted in Debre Berhan. 34 The possible reason might be that aging leads to neurotransmitter level decline, which affects communication in nerve cells, which leads to common mental disorder 33 and increased prevalence of physical comorbidity with advancing age.
The finding reveals that being divorced was positively associated with depression. Respondents who were divorced were 3.1 times more likely to develop depression. This finding was in line with the study conducted in India, 18 which showed that being divorced is a consistent risk factor for 
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Unrecognized depression among OPD patients in ethiopia depression. The finding implies the unstable marital relationship and the loss of partner increase the risk of having depression episodes. Low income was significantly associated with depression. Subjects who earned ,750 ETB were 1.9 times more likely to develop depression as compared to those who earned .1,200 ETB. This finding is consistent with the study done in Harar 35 and Debre Berhan. 34 This might be because an insufficient income leads to a feeling of being in a stressful and unsafe situation, which may trigger depression. People experiencing poverty face difficulties to fulfill basic needs and are unable to afford the treatment, and this interferes with their ability to participate in the productive activity. Higher levels of hopelessness toward the present rather than the future and lower level of satisfaction with life are some of the psychological impacts of low socioeconomic status.
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Conclusion
Unrecognized depression is common in nonpsychiatric OPDs in Adare Hospital. This study found that the prevalence rate of depression was 24.5% among the patient sample tested. The results revealed the magnitude of depression that is prevalent in the health-care service that goes undiagnosed and unmanaged. Age, sex, marital status, and monthly income were the most important risk factors for depressive episodes.
We recommended that health-care providers do through assessment to address common mental disorders, especially depression, and suggest that training to recognize and manage depression appropriately be given. There is a need to screen patients presenting in medical OPDs for depression. Healthcare service and health personnel need to recognize this as an important entity and focus on the detection of unrecognized forms of depression, which may be perhaps due to lack of awareness among patients and providers.
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